Privia Health Group Inc (PRVA)
Return on assets (ROA)
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net income (ttm) | US$ in thousands | 14,385 | 12,824 | 14,932 | 18,739 | 23,079 | 38,017 | 32,930 | 15,181 | -10,230 | -39,985 | -49,656 | -211,715 | -188,230 | -172,387 | -146,587 | 31,228 | 31,244 |
Total assets | US$ in thousands | 1,135,780,000 | 1,145,560 | 1,077,620 | 1,031,590 | 999,900 | 992,330 | 937,574 | 875,343 | 792,813 | 807,786 | 744,990 | 723,183 | 686,373 | 632,061 | 597,139 | 348,276 | 328,969 |
ROA | 0.00% | 1.12% | 1.39% | 1.82% | 2.31% | 3.83% | 3.51% | 1.73% | -1.29% | -4.95% | -6.67% | -29.28% | -27.42% | -27.27% | -24.55% | 8.97% | 9.50% |
December 31, 2024 calculation
ROA = Net income (ttm) ÷ Total assets
= $14,385K ÷ $1,135,780,000K
= 0.00%
The return on assets (ROA) of Privia Health Group Inc experienced fluctuations over the analyzed period, starting at a healthy 9.50% as of December 31, 2020. However, by June 30, 2021, the ROA plummeted to -24.55%, indicating a significant decline in profitability relative to its assets. This negative trend continued throughout the year, with ROA figures reaching -27.42% by December 31, 2021.
The following year, there was a slight improvement in ROA, reaching a low of -29.28% as of March 31, 2022, but still remaining negative. From this point onwards, the company started to gradually recover with ROA turning positive by March 31, 2023, at 1.73%, indicating a return to profitability relative to its assets.
The positive momentum continued into the following periods, with ROA figures progressively increasing to 3.83% as of September 30, 2023, before settling at 0.00% by December 31, 2024. This indicates that the company's profitability relative to its assets stabilized at the end of the analyzed period after experiencing significant fluctuations and a period of negative returns.
Peer comparison
Dec 31, 2024